Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/01/1991 | WO1991018639A1 Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty |
12/01/1991 | CA2084078A1 Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty |
12/01/1991 | CA2084074A1 Megakaryocyte colony stimulating factor and production thereof |
11/30/1991 | CA2064710A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
11/30/1991 | CA2043418A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i (hiv-1) gp120 and methods of use |
11/30/1991 | CA2043378A1 Process for reduction of certain cyclohexapeptide compounds |
11/30/1991 | CA2043372A1 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
11/30/1991 | CA2043049A1 Precursor forms of procine growth hormone releasing factor and related dna compounds |
11/29/1991 | WO1991018990A1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
11/28/1991 | WO1991018454A1 Compositions capable of blocking cytotoxicity of viral regulatory proteins and neurotoxic symptoms associated with retroviral infection |
11/28/1991 | WO1991018294A1 Synthetic peptides of human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunossay for diagnostic purposes |
11/28/1991 | WO1991018293A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
11/28/1991 | WO1991018098A1 Bone and cartilage inductive proteins |
11/28/1991 | WO1991018097A1 Cd46 variants |
11/28/1991 | WO1991018094A1 Particle-mediated transformation of woody plant species |
11/28/1991 | WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
11/28/1991 | WO1991018088A1 Adeno-associated virus (aav)-based eucaryotic vectors |
11/28/1991 | WO1991018018A1 Improved pseudomonas chimeric protein cytotoxic to human cells bearing il2 receptors |
11/28/1991 | WO1991018017A1 Method for preparing high-purity factor viii including a rapid immunoadsortpion step |
11/28/1991 | WO1991018016A1 Biologically active peptides containing d-2-alkyltryptophan |
11/28/1991 | WO1991018015A1 Alveolar surfactant proteins |
11/28/1991 | WO1991018013A1 Synthetic senescent cell antigen |
11/28/1991 | WO1991018011A1 Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
11/28/1991 | WO1991018010A1 Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
11/28/1991 | WO1991018005A1 Cloned genes encoding the d1 dopamine receptor |
11/28/1991 | WO1991018004A1 Antisense inhibitors of the human immunodeficiency virus |
11/28/1991 | WO1991017778A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample |
11/28/1991 | WO1991017773A2 New protein-polycation conjugates |
11/28/1991 | WO1991017768A1 Epitopes of the pre-s region of hepatitis b virus surface antigen |
11/28/1991 | WO1991017765A1 Fibrin binding domain polypeptides and uses and methods of producing same |
11/28/1991 | WO1991017763A1 PEPTIDE DERIVATIVES OF CYTOCHROME b558 AND THEIR USE AS MEDICAMENTS |
11/28/1991 | WO1991017762A1 Selective retroviral proteinase inhibitor |
11/28/1991 | WO1991017760A1 Composition of and treatment with biologically active peptides having d-amino acid residues |
11/28/1991 | WO1991017759A1 Trypanosomal immunosuppressive factor |
11/28/1991 | WO1991008478A3 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO) |
11/28/1991 | WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
11/28/1991 | CA2083150A1 Synthetic senescent cell antigen |
11/28/1991 | CA2082941A1 Bone and cartilage inductive proteins |
11/28/1991 | CA2082631A1 Antisense inhibitors of the human immunodeficiency virus |
11/28/1991 | CA2082277A1 Cd46 variants |
11/28/1991 | CA2064017A1 Particle-mediated transformation of woody plant species |
11/28/1991 | CA2063709A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
11/27/1991 | EP0458673A1 Growth-inhibitory factor and cDNA coding for growth inhibitory factor |
11/27/1991 | EP0458668A1 Papilloma virus probe (HPV66), particularly for the diagnosis of papillomaviral infections in vitro which accompany genital neoplasia, as well as products genetically and immunologically related to this papilloma virus |
11/27/1991 | EP0458437A1 Process for production of human nerve growth factor by genetic engineering |
11/27/1991 | EP0458167A1 Fatty acid-pulmonary surfactant conjugates |
11/27/1991 | EP0458072A1 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody |
11/27/1991 | EP0458064A2 Stabilization of somatotropins and other proteins by modification of cysteine residues |
11/27/1991 | EP0457898A1 Proteinase inhibitory agents and methods for their use |
11/27/1991 | EP0457875A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
11/27/1991 | EP0457837A1 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
11/27/1991 | EP0457786A1 Stabilized, potent grf analogs |
11/27/1991 | EP0457766A1 Drosophila receptors homologous to mammalian steroid receptors |
11/27/1991 | EP0425616A4 Use of animal-derived anti-microbial peptides for control of plant pathogens |
11/27/1991 | EP0201574B1 A preparation for the treatment of hemophilia a inhibitor patients and a process for producing such a preparation |
11/27/1991 | CN1056428A Actinobacillus pleuropneumoniae subunit vaccine |
11/27/1991 | CN1056427A Gene therapy for cell proliferative diseases |
11/26/1991 | WO1991018921A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
11/26/1991 | WO1991018618A2 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
11/26/1991 | US5068351 Catalytic amidation in the presence of phosphinic anhydride, cyclization |
11/26/1991 | US5068317 Methionine derived human growth hormones |
11/26/1991 | US5068315 Composition for the regulation of hair growth |
11/26/1991 | US5068314 Lipopolysaccharide-binding polypeptide |
11/26/1991 | US5068192 Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence |
11/26/1991 | US5068174 Incubation a specimen for detection of HIV antibodies, marking, reaction to form immunocomplexes and detection |
11/26/1991 | US5067961 Non-biodegradable two phase corneal implant and method for preparing same |
11/26/1991 | CA2083688A1 Growth factor which inhibits the growth of cells overexpressing the human oncogene erbb-2 |
11/26/1991 | CA2062758A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
11/25/1991 | WO1991018047A2 Mammalian expression of the bmp-2 family |
11/25/1991 | CA2082052A1 Mammalian expression of the bmp-2 family |
11/24/1991 | WO1991018107A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
11/24/1991 | CA2083598A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy |
11/23/1991 | CA2042973A1 Tgf-beta compositions |
11/22/1991 | CA2042635A1 Fatty acid-pulmonary surfactant conjugates |
11/21/1991 | EP0457738A1 Di-aminated derivative of SV-IV protein and method for the preparation thereof |
11/21/1991 | EP0457701A1 Derivatives of endogenous mediators, their salts, process for preparation, application and compositions containing them |
11/21/1991 | EP0457565A2 Milk-protein hydrolyzates and compositions for use as hair and skin treating agent |
11/21/1991 | EP0457527A1 Plasmids, transformed animal cells and process for producing foreign protein |
11/21/1991 | EP0457498A2 Bacillus thuringiensis genes encoding dipteran-active toxins |
11/21/1991 | EP0457438A2 Conjugate compounds containing aza-macrocycles, and processes for their preparation |
11/21/1991 | EP0457371A1 Method for the isolation of the tissue protein PP4 |
11/21/1991 | EP0457370A1 Method for the pasteurization of the tissue protein PP4 |
11/21/1991 | EP0457223A1 Stabilized fibroblast growth factor composition |
11/21/1991 | EP0456842A1 Medicinal application of m-csf |
11/21/1991 | EP0456766A1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE |
11/21/1991 | EP0456758A1 Anaphylatoxin-receptor ligands |
11/21/1991 | EP0456727A1 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof |
11/21/1991 | EP0456719A1 Anti-idiotype antibodies reactive with shared idiotopes expressed by human lymphomas and autoantibodies |
11/21/1991 | EP0456706A1 Molecular methods of hybrid seed production |
11/21/1991 | EP0456698A1 Novel expression vectors and methods for intracellular protein production |
11/21/1991 | EP0456667A1 Method for detecting the presence of mercury using microorganisms with mercury-enhanced bioluminescence. |
11/21/1991 | EP0456662A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants |
11/21/1991 | EP0456642A1 Somatotropin analogs |
11/21/1991 | EP0413766A4 Synthetic peptides for arterial imaging |
11/20/1991 | CN1056245A Bcrf1 antagonists for treating epstein-barr virus infections |
11/20/1991 | CN1056240A Inhibition nf allograft and concordant xenograft rejection |
11/19/1991 | US5066794 Process for preparing a disaccharide derivative |
11/19/1991 | US5066787 Blood coagulation inhibiting proteins, processes for preparing them and their uses |
11/19/1991 | US5066786 Adsorption on a clean porous glass column, elution with sodium chloride and acetic acid |
11/19/1991 | US5066783 Antiviral peptides and means for treating herpes infections |